Related Experiment Videos
Psoriasis in infancy: therapy with calcipotriene ointment
1Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York 10025, USA.
Cutis
|January 5, 2002
Summary
Topical calcipotriene offers a safe and effective alternative for treating infantile psoriasis when corticosteroids are insufficient. This vitamin D analog demonstrated significant benefits in an infant case study.
Area of Science:
- Dermatology
- Pediatrics
- Pharmacology
Background:
- Infantile psoriasis presents unique therapeutic challenges compared to atopic or seborrheic dermatitis.
- Generalized inflammation and intertriginous/scalp involvement limit topical corticosteroid efficacy in infants.
- Standard topical corticosteroids may not be sufficient for managing severe infantile psoriasis.
Observation:
- An infant with generalized psoriasis showed limited response to conventional topical corticosteroids.
- Topical calcipotriene was administered to the infant for treatment of psoriasis.
- Calcium metabolism was monitored and remained within normal limits during calcipotriene therapy.
Findings:
- Topical calcipotriene provided greater therapeutic benefit than standard corticosteroid medications for the infant.
- The infant's psoriasis showed marked improvement with calcipotriene treatment.
- Laboratory tests confirmed normal calcium metabolism throughout the treatment period.
Implications:
- Topical calcipotriene represents a potentially safe and effective treatment option for infantile psoriasis.
- This approach may overcome limitations associated with topical corticosteroid use in infants.
- Further research into calcipotriene for pediatric psoriasis is warranted.